Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 25 Sep 24 424B3 Prospectus supplement
- 16 Aug 24 424B3 Prospectus supplement
- 14 Aug 24 EFFECT Notice of effectiveness
- 12 Aug 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Aug 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 19 Jul 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
27 Jun 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 May 24 S-4 Registration of securities issued in business combination transactions
KTRA similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the inclusion in this Registration Statement on Form S-4 of Kintara Therapeutics, Inc. of our report dated April 1, 2024, related to the consolidated financial statements of TuHURA Biosciences, Inc. as of and for the years ended December 31, 2023 and 2022, and to the reference to us under the heading “Experts” in this Registration Statement.
/s/ Cherry Bekaert LLP
Tampa, Florida
June 27, 2024